The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Cancer treatment and survivorship statistics, 2012
Open accessAbstract
Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER‐Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers. CA Cancer J Clin 2012. Published 2012 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Self-citationReduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Davies, L., & Welch, H. G. (2006) · JAMA · doi:10.1001/jama.295.18.2164 · Cited by 3,369
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Self-citationEffect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449 · cited 1×
“A recent meta-analysis found that 30% to 40% of cancer patients had diagnosable mood disorders.(91) The early detection and treatment of distress can improve treatment adherence and patient-provider communication and decrease the risk of severe depression or anxiety.”
BackgroundFrom Cancer Patient to Cancer Survivor: Lost in Transition
(2005) · PsycEXTRA Dataset · doi:10.1037/e720092007-001 · Cited by 2,285
Cited by
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Self-citationBrenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Self-citationZamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Breast Cancer Statistics, 2022
Giaquinto, A. N., Sung, H., Miller, K. D., Kramer, J. L., Newman, L. A., Minihan, A., Jemal, A., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21754 · Cited by 2,286
Self-citationZamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Heart Failure: Preventing Disease and Death Worldwide
Ponikowski, P., Anker, S. D., AlHabib, K. F., Cowie, M. R., Force, T. L., Hu, S., Jaarsma, T., Krum, H., Rastogi, V., Rohde, L. E., et al. (2014) · ESC Heart Failure · doi:10.1002/ehf2.12005 · Cited by 1,694
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
McArthur, G. A., Chapman, P. B., Robert, C., Larkin, J., Haanen, J. B., Dummer, R., Ribas, A., Hogg, D., Hamid, O., Ascierto, P. A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70012-9 · Cited by 977
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Di Domenico, D., Croy, S., & MacGillivray, S. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 946
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M. E., Li, J., Xu, H. E., Melcher, K., & Yong, E.-L. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 943
Yin, W., Yan, L., Yu, J., Tian, G., Zhou, L., Zheng, X., Zhang, X., Yong, Y., Li, J., Gu, Z., et al. (2014) · ACS Nano · doi:10.1021/nn501647j · Cited by 923
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Curigliano, G., Cardinale, D., Dent, S., Criscitiello, C., Aseyev, O., Lenihan, D., & Cipolla, C. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 723
Prevention of Anthracycline-Induced Cardiotoxicity
Vejpongsa, P., & Yeh, E. T. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1167 · Cited by 671
Mechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660
Erho, N., Crisan, A., Vergara, I. A., Mitra, A. P., Ghadessi, M., Buerki, C., Bergstralh, E. J., Kollmeyer, T., Fink, S., Haddad, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066855 · Cited by 644
Schmid, D., & Leitzmann, M. F. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu012 · Cited by 625
Weber, J. S., Kudchadkar, R. R., Yu, B., Gallenstein, D., Horak, C. E., Inzunza, H. D., Zhao, X., Martinez, A. J., Wang, W., Gibney, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.4802 · Cited by 535
Li, T., Kung, H.-J., Mack, P. C., & Gandara, D. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3753 · Cited by 518
Kipps, T. J., Stevenson, F. K., Wu, C. J., Croce, C. M., Packham, G., Wierda, W. G., O'Brien, S., Gribben, J., & Rai, K. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.96 · Cited by 517
Radiation enteropathy—pathogenesis, treatment and prevention
Hauer-Jensen, M., Denham, J. W., & Andreyev, H. J. N. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.46 · Cited by 489
Huang, C.-Y., Ju, D.-T., Chang, C.-F., Muralidhar Reddy, P., & Velmurugan, B. K. (2017) · BioMedicine · doi:10.1051/bmdcn/2017070423 · Cited by 481
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
McCabe, M. S., Bhatia, S., Oeffinger, K. C., Reaman, G. H., Tyne, C., Wollins, D. S., & Hudson, M. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.6854 · Cited by 469
Exercise as a prescription for patients with various diseases
Luan, X., Tian, X., Zhang, H., Huang, R., Li, N., Chen, P., & Wang, R. (2019) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2019.04.002 · Cited by 441
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Burger, J. A., & Wiestner, A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.121 · Cited by 431
Impairment‐driven cancer rehabilitation: An essential component of quality care and survivorship
Silver, J. K., Baima, J., & Mayer, R. S. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21186 · Cited by 431
Adam, M. A., Pura, J., Gu, L., Dinan, M. A., Tyler, D. S., Reed, S. D., Scheri, R., Roman, S. A., & Sosa, J. A. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000925 · Cited by 427
Cisplatin is retained in the cochlea indefinitely following chemotherapy
Breglio, A. M., Rusheen, A. E., Shide, E. D., Fernandez, K. A., Spielbauer, K. K., McLachlin, K. M., Hall, M. D., Amable, L., & Cunningham, L. L. (2017) · Nature Communications · doi:10.1038/s41467-017-01837-1 · Cited by 412
Artificial intelligence in radiation oncology
Huynh, E., Hosny, A., Guthier, C., Bitterman, D. S., Petit, S. F., Haas-Kogan, D. A., Kann, B., Aerts, H. J. W. L., & Mak, R. H. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0417-8 · Cited by 419
American Cancer Society prostate cancer survivorship care guidelines
Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., Salner, A. L., Zelefsky, M. J., Aragon‐Ching, J. B., Slovin, S. F., et al. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21234 · Cited by 398
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., Pecot, C. V., Zhao, Y., Reynolds, S., Cheng, H., Rupaimoole, R., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.020 · Cited by 394
Radiodermatitis: A Review of Our Current Understanding
Singh, M., Alavi, A., Wong, R., & Akita, S. (2016) · American Journal of Clinical Dermatology · doi:10.1007/s40257-016-0186-4 · Cited by 391
Cancer progression and the invisible phase of metastatic colonization
Klein, C. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00300-6 · Cited by 375
van der Paardt, M. P., Zagers, M. B., Beets-Tan, R. G. H., Stoker, J., & Bipat, S. (2013) · Radiology · doi:10.1148/radiol.13122833 · Cited by 372
Loriot, Y., Bianchini, D., Ileana, E., Sandhu, S., Patrikidou, A., Pezaro, C., Albiges, L., Attard, G., Fizazi, K., De Bono, J. S., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt136 · Cited by 357
Economic Burden of Cancer Survivorship Among Adults in the United States
Guy, G. P., Ekwueme, D. U., Yabroff, K. R., Dowling, E. C., Li, C., Rodriguez, J. L., de Moor, J. S., & Virgo, K. S. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1241 · Cited by 351
Self-citationAdam, M. A., Pura, J., Goffredo, P., Dinan, M. A., Reed, S. D., Scheri, R. P., Hyslop, T., Roman, S. A., & Sosa, J. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.8391 · Cited by 335
Deng, X., Liang, S., Cai, X., Huang, S., Cheng, Z., Shi, Y., Pang, M., Ma, P., & Lin, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01716 · Cited by 319
Hamoen, E. H. J., de Rooij, M., Witjes, J. A., Barentsz, J. O., & Rovers, M. M. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.033 · Cited by 316
Circular RNA: a novel biomarker and therapeutic target for human cancers
Lei, B., Tian, Z., Fan, W., & Ni, B. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.28047 · Cited by 313
Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
Strehl, C., Ehlers, L., Gaber, T., & Buttgereit, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01744 · Cited by 308
lnc RNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI
Zhu, M., Chen, Q., Liu, X., Sun, Q., Zhao, X., Deng, R., Wang, Y., Huang, J., Xu, M., Yan, J., et al. (2014) · The FEBS Journal · doi:10.1111/febs.12902 · Cited by 299
Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer
Sanoff, H. K., Deal, A. M., Krishnamurthy, J., Torrice, C., Dillon, P., Sorrentino, J., Ibrahim, J. G., Jolly, T. A., Williams, G., Carey, L. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju057 · Cited by 283
Mladenov, E., Magin, S., Soni, A., & Iliakis, G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00113 · Cited by 290
Kneuertz, P. J., Chang, G. J., Hu, C.-Y., Rodriguez-Bigas, M. A., Eng, C., Vilar, E., Skibber, J. M., Feig, B. W., Cormier, J. N., & You, Y. N. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.3572 · Cited by 284
Soy isoflavones and prostate cancer: A review of molecular mechanisms
Mahmoud, A. M., Yang, W., & Bosland, M. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.12.010 · Cited by 281
Application of Near-Infrared Dyes for Tumor Imaging, Photothermal, and Photodynamic Therapies
Yuan, A., Wu, J., Tang, X., Zhao, L., Xu, F., & Hu, Y. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23356 · Cited by 280
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
Hsieh, A., & Edlind, M. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122876 · Cited by 276
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
Gül, N., Babes, L., Siegmund, K., Korthouwer, R., Bögels, M., Braster, R., Vidarsson, G., ten Hagen, T. L. M., Kubes, P., & van Egmond, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66776 · Cited by 275
Wang, S., Chen, Y., Li, X., Gao, W., Zhang, L., Liu, J., Zheng, Y., Chen, H., & Shi, J. (2015) · Advanced Materials · doi:10.1002/adma.201503869 · Cited by 269
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
Travis, L. B., Wahnefried, W. D., Allan, J. M., Wood, M. E., & Ng, A. K. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.41 · Cited by 264
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
Fulton, M. D., & Najahi-Missaoui, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076615 · Cited by 258
Lenz, H.-J., Ou, F.-S., Venook, A. P., Hochster, H. S., Niedzwiecki, D., Goldberg, R. M., Mayer, R. J., Bertagnolli, M. M., Blanke, C. D., Zemla, T., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02258 · Cited by 246
The prognostic value of PD-L1 expression for non-small cell lung cancer patients: A meta-analysis
Wang, A., Wang, H. Y., Liu, Y., Zhao, M. C., Zhang, H. J., Lu, Z. Y., Fang, Y. C., Chen, X. F., & Liu, G. T. (2015) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2015.01.020 · Cited by 255
Treatment of cancer in sub-Saharan Africa
Kingham, T. P., Alatise, O. I., Vanderpuye, V., Casper, C., Abantanga, F. A., Kamara, T. B., Olopade, O. I., Habeebu, M., Abdulkareem, F. B., & Denny, L. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70472-2 · Cited by 255
Garland, M., Yim, J. J., & Bogyo, M. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2015.12.003 · Cited by 254
Adiposity and risk of thyroid cancer: A systematic review and meta-analysis
Schmid, D., Ricci, C., Behrens, G., & Leitzmann, M. F. (2015) · Obesity Reviews · doi:10.1111/obr.12321 · Cited by 244
Diagnostics and Epidemiology of Colorectal Cancer
Kolligs, F. T. (2016) · Visceral Medicine · doi:10.1159/000446488 · Cited by 223
Guy, G. P., Yabroff, K. R., Ekwueme, D. U., Smith, A. W., Dowling, E. C., Rechis, R., Nutt, S., & Richardson, L. C. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1425 · Cited by 201
Stagl, J. M., Bouchard, L. C., Lechner, S. C., Blomberg, B. B., Gudenkauf, L. M., Jutagir, D. R., Glück, S., Derhagopian, R. P., Carver, C. S., & Antoni, M. H. (2015) · Cancer · doi:10.1002/cncr.29076 · Cited by 174
Badrising, S., van der Noort, V., van Oort, I. M., van den Berg, H. P., Los, M., Hamberg, P., Coenen, J. L., van den Eertwegh, A. J. M., de Jong, I. J., Kerver, E. D., et al. (2014) · Cancer · doi:10.1002/cncr.28518 · Cited by 136
Morris, V., Overman, M. J., Jiang, Z.-Q., Garrett, C., Agarwal, S., Eng, C., Kee, B., Fogelman, D., Dasari, A., Wolff, R., et al. (2014) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2014.06.001 · Cited by 132
Diagnostic evaluation of a deep learning model for optical diagnosis of colorectal cancer
Zhou, D., Tian, F., Tian, X., Sun, L., Huang, X., Zhao, F., Zhou, N., Chen, Z., Zhang, Q., Yang, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16777-6 · Cited by 123
Lee, W. H., Choong, L. Y., Jin, T. H., Mon, N. N., Chong, S., Liew, C. S., Putti, T., Lu, S. Y., Harteneck, C., & Lim, Y. P. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.39 · Cited by 121
Mitochondrial complex II, a novel target for anti-cancer agents
Kluckova, K., Bezawork-Geleta, A., Rohlena, J., Dong, L., & Neuzil, J. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.10.015 · Cited by 104
Depression in adolescents and young adults with cancer
Park, E. M., & Rosenstein, D. L. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.2/epark · Cited by 108
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez, J. N., Wentzensen, N., Maurer, M. J., Hawthorne, K. M., Voss, J. S., Kroneman, T. N., Famuyide, A. O., Clayton, A. C., Halling, K. C., Kerr, S. E., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.552 · Cited by 107
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
Chen, R., Lai, L. A., Sullivan, Y., Wong, M., Wang, L., Riddell, J., Jung, L., Pillarisetty, V. G., Brentnall, T. A., & Pan, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08436-6 · Cited by 92
Sun, Q., Tan, S. H., Chen, Q., Ran, R., Hui, Y., Chen, D., & Zhao, C.-X. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00904 · Cited by 100
Winters-Stone, K. M., Neil, S. E., & Campbell, K. L. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2012-091732 · Cited by 98
Li, J., Lai, Y., Cao, Y., Du, T., Zeng, L., Wang, G., Chen, X., Chen, J., Yu, Y., Zhang, S., et al. (2015) · Medical Oncology · doi:10.1007/s12032-014-0444-3 · Cited by 91
Clinical use of proteasome inhibitors in the treatment of multiple myeloma
Merin, N., & Kelly, K. (2014) · Pharmaceuticals · doi:10.3390/ph8010001 · Cited by 90
Childhood Adversity and Cumulative Life Stress: Risk Factors for Cancer-Related Fatigue
Bower, J. E., Crosswell, A. D., & Slavich, G. M. (2014) · Clinical Psychological Science · doi:10.1177/2167702613496243 · Cited by 86
Benamar, M., Guessous, F., Du, K., Corbett, P., Obeid, J., Gioeli, D., Slingluff, C. L., & Abbas, T. (2016) · eBioMedicine · doi:10.1016/j.ebiom.2016.06.023 · Cited by 77
Sanoff, H. K., Moon, D. H., Moore, D. T., Boles, J., Bui, C., Blackstock, W., O'Neil, B. H., Subramaniam, S., McRee, A. J., Carlson, C., et al. (2019) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2019.02.021 · Cited by 72
A Systematic Review of the Safety and Effect of Neurofeedback on Fatigue and Cognition
Luctkar-Flude, M., & Groll, D. (2015) · Integrative Cancer Therapies · doi:10.1177/1534735415572886 · Cited by 69
Objectively Measured Sedentary Time Is Related to Quality of Life among Cancer Survivors
George, S. M., Alfano, C. M., Groves, J., Karabulut, Z., Haman, K. L., Murphy, B. A., & Matthews, C. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087937 · Cited by 66
Andreopoulou, E., & Sparano, J. A. (2013) · Current Breast Cancer Reports · doi:10.1007/s12609-012-0097-1 · Cited by 65
Piskol, R., Huw, L., Sergin, I., Kljin, C., Modrusan, Z., Kim, D., Kljavin, N., Tam, R., Patel, R., Burton, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3032 · Cited by 62
Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review
Playdon, M., Thomas, G., Sanft, T., Harrigan, M., Ligibel, J., & Irwin, M. (2013) · Current Breast Cancer Reports · doi:10.1007/s12609-013-0113-0 · Cited by 62
Stress and non-stress roles of inflammatory signals during HSC Emergence and maintenance
Clapes, T., Lefkopoulos, S., & Trompouki, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00487 · Cited by 62
Martins, A. R., Crespo, C., Salvador, Á., Santos, S., Carona, C., & Canavarro, M. C. (2018) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-018-9547-x · Cited by 48
Pinheiro, L. C., Wheeler, S. B., Chen, R. C., Mayer, D. K., Lyons, J. C., & Reeve, B. B. (2015) · Cancer · doi:10.1002/cncr.29205 · Cited by 45
Phillips, S. M., Stampfer, M. J., Chan, J. M., Giovannucci, E. L., & Kenfield, S. A. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0426-2 · Cited by 42
Leach, C. R., Troeschel, A. N., Wiatrek, D., Stanton, A. L., Diefenbach, M., Stein, K. D., Sharpe, K., & Portier, K. (2017) · Annals of Behavioral Medicine · doi:10.1007/s12160-017-9880-6 · Cited by 40
Self-citationHanly, P., Maguire, R., Hyland, P., & Sharp, L. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-014-2551-2 · Cited by 42
Dienstmann, R., Salazar, R., & Tabernero, J. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.91 · Cited by 38
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer
Bartolacci, C., Andreani, C., Curcio, C., Occhipinti, S., Massaccesi, L., Giovarelli, M., Galeazzi, R., Iezzi, M., Tilio, M., Gambini, V., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0179 · Cited by 37
Coping Among Breast Cancer Survivors: A Confirmatory Factor Analysis of the Brief COPE
Rand, K. L., Cohee, A. A., Monahan, P. O., Wagner, L. I., Shanahan, M. L., & Champion, V. L. (2019) · Journal of Nursing Measurement · doi:10.1891/1061-3749.27.2.259 · Cited by 32
Comprehensive cancer control: promoting survivor health and wellness
Rohan, E. A., Miller, N., Bonner, F., Fultz-Butts, K., Pratt-Chapman, M. L., Alfano, C. M., Santiago, K. C., Bergman, K., & Tai, E. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1107-z · Cited by 29
Salvatore, A. L., Ahn, S., Jiang, L., Lorig, K., & Ory, M. G. (2015) · Psycho-Oncology · doi:10.1002/pon.3783 · Cited by 24
Averyt, J. C., & Nishimoto, P. W. (2014) · PubMed Central · doi:10.3978/j.issn.2078-6891.2014.058 · Cited by 22
Ranzani, M., Annunziato, S., Calabria, A., Brasca, S., Benedicenti, F., Gallina, P., Naldini, L., & Montini, E. (2014) · Molecular Therapy · doi:10.1038/mt.2014.174 · Cited by 17
Koll, T. T., Semin, J. N., Grieb, B. M., & Dale, W. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0623-4 · Cited by 16
Rapamycin inhibited the function of lung CSCs via SOX2
Xie, L.-X., Sun, F.-F., He, B.-F., Zhan, X.-F., Song, J., Chen, S.-S., Yu, S.-C., & Ye, X.-Q. (2016) · Tumor Biology · doi:10.1007/s13277-015-4341-y · Cited by 12
Implementation of a mobile inpatient quality of life (QoL) assessment for oncology nursing
Schuler, M. K., Trautmann, F., Radloff, M., Schmädig, R., Hentschel, L., Eberlein-Gonska, M., Petzold, T., Vetter, H., Oberlack, S., Ehninger, G., et al. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3163-9 · Cited by 10
Nock, N. L., Jiang, H., Borato, L., Alberts, J., & Dimitropoulos, A. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-0124-7 · Cited by 4
Metadata
- Authors
- Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., Lin, C., Leach, C., Cannady, R. S., Cho, H., Scoppa, S., Hachey, M., Kirch, R., Jemal, A., & Ward, E.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2012-06-14
- Volume
- 62
- Issue
- 4
- Pages
- 220-241
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2096065464
- Cited by
- 2,928
- References
- 176
- FWCI
- 179.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.